Metformin 500 mg + Glimepiride 2 mg Tablets
Metformin 500 mg + Glimepiride 2 mg Tablets
Product Overview
[Brand Name] is an advanced oral antidiabetic formulation designed to deliver effective glycemic control through a synergistic combination of Metformin and Glimepiride. This dual therapy targets both insulin resistance and pancreatic insulin secretion, offering a balanced approach to long-term diabetes management.
Developed under stringent quality standards, [Brand Name] ensures consistent efficacy, safety, and patient compliance — empowering physicians to achieve optimal therapeutic outcomes in Type 2 Diabetes Mellitus.
Therapeutic Benefits / Key Features
- Provides dual mechanism of action for superior glycemic control.
- Enhances insulin sensitivity and pancreatic function simultaneously.
- Sustained-release formulation improves patient adherence and convenience.
- Backed by clinically proven efficacy and metabolic safety profile.
Brand Composition
Each film-coated tablet contains:
- Metformin Hydrochloride I.P. 500 mg
- Glimepiride I.P. 2 mg
Why this formulation matters
- Combines the most trusted first-line and second-line agents in diabetes management.
- Reduces both fasting and postprandial glucose levels effectively.
- Minimizes risk of hypoglycemia compared to monotherapy.
- Proven to improve glycemic parameters and delay disease progression.
Division Identity
Part of Yaselle Diaxen – Diabetes & Endocrine Care Division
Committed to advancing endocrine health through evidence-based innovation.